Skip to main content

Table 4 Factors associated with mortality among patients who completed follow-up (N = 580)a

From: Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India

Clinical Factor Survived, N = 546, n (%) Died, N = 34, n (%) Unadjusted OR (95% CI) p-value Adjusted ORb (95% CI) p-value
Male sex 321 (59) 23 (68) 1.5 (0.7–3.4) 0.37
Child < 12 years 267 (49) 11 (32) 0.5 (0.2–1.1) 0.08 0.2 (0.1–0.4) < 0.01
Income < 5000 INR / month 197 (36) 15 (44) 1.4 (0.6–3) 0.36
Diabetes 18 (3) 1 (3) 0.9 (0–6) 1
HIV 56 (10) 7 (21) 2 (0.6–5.7) 0.17
Diarrhea 110 (20) 9 (26) 1.4 (0.6–3.3) 0.38
Cough 278 (51) 13 (38) 0.6 (0.3–1.3) 0.16
ICU admission 96 (18) 19 (56) 6.8 (3.1–15.6) < .01 14.7 (6.1–36.9) < 0.01
Admission ceftriaxone-resistant EB colonization 52 (10) 2 (6) 0.6 (0.1–2.4) 0.76
Follow-up ceftriaxone-resistant EB colonization 53 (10) 8 (24) 2.9 (1.1–6.9) 0.02 2.4 (0.9–6.0) 0.06
Acquisition of ceftriaxone-resistant EB colonization 37 (7) 6 (18) 2.8 (0.9–7.7) 0.04
  1. OR odds ratio, INR Indian Rupees, ICU intensive care unit, EB Enterobacteriaceae
  2. aMortality data was not available for 40 (6%) of patients who completed follow-up perirectal swab collection
  3. bAdjusted for child < 12 years, ICU admission, and colonization with ceftriaxone-resistant EB at follow-up